Top Markets
Coin of the day
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Classement en actions #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Prix de l'action
$0.00023723
Dernière synchronisation: 2024-08-26
Capitalisation boursière
$1.41K
Changement (1 jour)
111.67%
Changement (1 an)
0.00%
Pays
FR
Échange Pharnext S.A. (ALPHA)

Catégorie

EPS pour Pharnext S.A. (ALPHA)
EPS au December 2023 TTM : $-77.35M
Selon les derniers rapports financiers et le cours de l'action de Pharnext S.A., l’EPS actuel de la société (TTM) est de $-77.35M. À la fin de 2022, la société avait un EPS de $-11.16K une diminution par rapport à celui de 2021, qui était de $-11.45K.
Historique de l'EPS de Pharnext S.A. de 2013 à 2026
EPS à la fin de chaque année
Année EPS Changez
2026 (TTM) $-77.35M 35,598,509.46%
2023 $-217.28 -98.05%
2022 $-11.16K -2.49%
2021 $-11.45K 69.15%
2020 $-6.77K -21.06%
2019 $-8.57K -15.43%
2018 $-10.14K -100.00%
2017 $-6.00Qa 14.04%
2016 $-5.26Qa 44,068,612,420.18%
2015 $-11.94M -8.06%
2014 $-12.98M 1.29%
2013 $-12.82M 0.00%
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
$17.32 -100.00%
US
$27.74 -100.00%
NL
- -
CH
$13.70 -100.00%
BE
- -
KR